Company intelligence / Profile preview

Elysia Capital

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Elysia Capital is the single family office of the Buono-Lopera family, focused on social impact investments across sustainable innovation, education, well-being, arts, and culture. The firm also acts as an active biotech investor, as evidenced by its participation in Kither Biotech's €5.6m Series A round for programs targeting cystic fibrosis and pulmonary diseases. Founders Stefano Buono and Maribel Lopera Sierra bring significant biotech expertise, having held key roles at Advanced Accelerator Applications.

Therapeutic areas: Pulmonology
Industry: Investors

Beyond the preview

Go deeper on Elysia Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elysia Capital.

Explore the full profile